Back to Search Start Over

Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs.

Authors :
Micieli F
Santangelo B
Reynaud F
Mirra A
Napoleone G
Della Valle G
Portier KG
Vesce G
Source :
Veterinary anaesthesia and analgesia [Vet Anaesth Analg] 2017 Jul; Vol. 44 (4), pp. 703-709. Date of Electronic Publication: 2017 Apr 05.
Publication Year :
2017

Abstract

Objective: To compare the clinical effects and sedation scores following either intranasal (IN) or intramuscular (IM) administration of dexmedetomidine in dogs.<br />Study Design: Prospective, blinded, randomized, clinical study.<br />Animals: A total of 20 client-owned dogs scheduled for noninvasive diagnostic procedures.<br />Methods: Dogs were allocated to be administered dexmedetomidine 0.02 mg kg <superscript>-1</superscript> IN (IN group) or IM (IM group). Sedation was scored before and at 5 minute intervals (for 45 minutes) after drug administration using a composite simple descriptive sedation scale giving a score of 0 (not sedated) to 13 (well sedated). Respiratory frequency (f <subscript>R</subscript> ), heart rate, haemoglobin oxygen saturation (SpO <subscript>2</subscript> ) and noninvasive arterial blood pressure were recorded every 5 minutes for 45 minutes. Normally distributed data were analyzed using two-way ANOVA and post hoc Sidak's multiple comparison test. Non-normally distributed data were compared using the Scheier Ray Hare test and post hoc Mann-Whitney U test. Statistical significance was set at p<0.05.<br />Results: Weight, age and sex were not different between groups. Dexmedetomidine onset of action after IN administration was not shorter compared to IM administration (6.3±3.3 versus 9.4±4.6 minutes, p=0.120). Sedation score in the IN group was higher [10 (0-11)] compared to the IM group [6 (0-8)] (p<0.001). At time of peak sedation, heart rate decreased 56% from baseline values in the IM group, and 18% in the IN group. No significant differences in SpO <subscript>2</subscript> and f <subscript>R</subscript> were found between the two groups at any time point. No undesirable effects were observed.<br />Conclusions and Clinical Relevance: Intranasal dexmedetomidine 0.02 mg kg <superscript>-1</superscript> produced effective sedation with less bradycardia and more profound sedation compared to IM administration in healthy dogs and may be considered as an alternative route for dexmedetomidine administration in dogs.<br /> (Copyright © 2017 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1467-2995
Volume :
44
Issue :
4
Database :
MEDLINE
Journal :
Veterinary anaesthesia and analgesia
Publication Type :
Academic Journal
Accession number :
28716686
Full Text :
https://doi.org/10.1016/j.vaa.2016.08.009